170 related articles for article (PubMed ID: 31271081)
1. Emerging trends in the treatment of rectal cancer.
Minsky BD
Acta Oncol; 2019 Oct; 58(10):1343-1351. PubMed ID: 31271081
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery.
Tomasello G; Ghidini M; Petrelli F
Eur J Cancer; 2019 Feb; 108():97-99. PubMed ID: 30648634
[No Abstract] [Full Text] [Related]
3. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
[TBL] [Abstract][Full Text] [Related]
4. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
5. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
8. Do We Have to Treat All T3 Rectal Cancer the Same Way?
Valadão M; Dias JA; Araújo R; Cesar D
Clin Colorectal Cancer; 2020 Dec; 19(4):231-235. PubMed ID: 32839078
[TBL] [Abstract][Full Text] [Related]
9. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
[TBL] [Abstract][Full Text] [Related]
10. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
[TBL] [Abstract][Full Text] [Related]
11. [Rectal cancer: Towards personalized medicine].
Vendrely V; Benoist S
Cancer Radiother; 2021 Oct; 25(6-7):650-654. PubMed ID: 34266737
[TBL] [Abstract][Full Text] [Related]
12. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer.
Gollins S; Sebag-Montefiore D
Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):146-151. PubMed ID: 26645661
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
[TBL] [Abstract][Full Text] [Related]
16. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
17. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
18. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
[TBL] [Abstract][Full Text] [Related]
19. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant radiotherapy for rectal cancer management.
Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
